Search
Crescent Biopharma Ord Shs
CBIOAdd to Watchlist
19.970USD
-1.260-5.93%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
277.43MMarket Cap
LossP/E TTM
More Details of Company
Crescent Biopharma Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Crescent Biopharma Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Bruce Johnson
Mr. Bruce Johnson
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
--
--
Mr. Chinmaya Rath
Mr. Chinmaya Rath
Senior Vice President, Chief Business Officer
Senior Vice President, Chief Business Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Bruce Johnson
Mr. Bruce Johnson
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
--
--
Mr. Chinmaya Rath
Mr. Chinmaya Rath
Senior Vice President, Chief Business Officer
Senior Vice President, Chief Business Officer
--
--
Revenue Breakdown
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
10.00K
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
14.99%
BVF Partners L.P.
9.97%
Fairmount Funds Management LLC
9.97%
VR Adviser, LLC
7.74%
Forbion Capital Partners
6.09%
Other
51.25%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
14.99%
BVF Partners L.P.
9.97%
Fairmount Funds Management LLC
9.97%
VR Adviser, LLC
7.74%
Forbion Capital Partners
6.09%
Other
51.25%
Shareholder Types
Shareholders
Proportion
Hedge Fund
36.96%
Investment Advisor
22.65%
Venture Capital
16.00%
Investment Advisor/Hedge Fund
11.51%
Corporation
5.17%
Private Equity
1.65%
Individual Investor
0.99%
Research Firm
0.40%
Pension Fund
0.04%
Other
4.64%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
74
14.38M
82.13%
--
2026Q1
140
25.15M
91.21%
+12.78M
2025Q4
127
14.27M
51.79%
+2.00M
2025Q3
130
11.32M
81.48%
+344.37K
2025Q2
131
10.75M
77.39%
+10.23M
2025Q1
123
307.17K
47.59%
-204.60K
2024Q4
132
303.23K
47.01%
-167.56K
2024Q3
125
177.68K
27.55%
-170.88K
2024Q2
126
261.75K
40.60%
-129.02K
2024Q1
127
376.48K
58.41%
+13.40K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
4.13M
15%
+2.72M
+192.19%
Dec 31, 2025
BVF Partners L.P.
2.75M
9.97%
+1.36M
+98.06%
Dec 31, 2025
Fairmount Funds Management LLC
2.75M
9.97%
+1.36M
+97.99%
Dec 31, 2025
VR Adviser, LLC
2.13M
7.74%
+745.71K
+53.73%
Dec 31, 2025
Forbion Capital Partners
1.68M
6.09%
+1.68M
--
Dec 31, 2025
Vestal Point Capital, LP
1.50M
5.44%
+1.50M
--
Dec 31, 2025
1Globe Capital, L.L.C.
1.43M
5.17%
+528.72K
+58.96%
Oct 07, 2025
Opaleye Management Inc.
1.18M
4.28%
+1.18M
--
Dec 31, 2025
Tang Capital Management, LLC
872.40K
3.17%
+172.40K
+24.63%
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
Avantis US Small Cap Equity ETF
Proportion0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Jun 05, 2025
Merger
100→1
Date
Ex-dividend Date
Type
Ratio
Jun 05, 2025
Merger
100→1
